Search Results - David Cescon

  • Showing 1 - 3 results of 3
Refine Results
  1. 1

    Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Cancer in Canada: A Dilemma Increasingly Difficult to Explain by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

    Published in Current Oncology (2022-12-01)
    Get full text
    Article


  2. 2

    Reply to Trudeau, M.; Fraser, B. The CADTH pCODR Expert Review Committee Process Explained. Comment on “Rayson et al. Access to Neoadjuvant Pertuzumab for HER2 Positive Breast Canc... by Daniel Rayson, Sonal Gandhi, Anil A. Joy, Christine Brezden-Masley, Karen A. Gelmon, Sandeep Sehdev, David Cescon, Stephen Chia

    Published in Current Oncology (2023-05-01)
    Get full text
    Article


  3. 3

    FAM72A promotes UNG2 degradation and mutagenesis in human cancer cells by Yuqing Feng, Philip Barbulescu, Chetan K. Chana, Melika Shirdarreh, Hong Yang, Lizhen Wu, Sami Mamand, Mohammad Kashem, Amin Zia, Ming Han, Julissa Tsao, Trevor Pugh, David Cescon, David G. Schatz, Frank Sicheri, Alberto Martin, Rossanna C. Pezo

    Published in Scientific Reports (2025-07-01)
    Get full text
    Article


Search Tools: